PROM1 and ependymoma: We found with the ChemoID assay that increasing concentrations of BITC ranging from 2.5 μM to 20 μM decreased the viability of CD133(+) ependymoma cells of Patient 1 from 90% to 62% in a statistically significant manner (Figure 5A).